Dietary Intake is Associated with miR-31 and miR-375 Expression in Patients with Head and Neck Squamous Cell Carcinoma

References

• IARC. International Agency for Research on Cancer. New Global Cancer Data GLOBOCAN 2018. 2018. [accessed 2020 Dec 9]. https://www.uicc.org/news/global-cancer-data-globocan-2018.
   Google Scholar
• Konings H, Stappers S, Geens M, De Winter BY, Lamote K, van Meerbeeck JP, Specenier P, Vanderveken OM, Ledeganck KJ. A literature review of the potential diagnostic biomarkers of head and neck neoplasms. Front Oncol. 2020;10:1020 doi:10.3389/fonc.2020.01020
   PubMed Web of Science ®Google Scholar
• Jamali Z, Asl N, Attaran R, Pournagiazar F, Ghertasi S, Ahmadpour F. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma : a systematic review and meta-analysis. Oral Oncology. 2015;51(4):321–331. doi:10.1016/j.oraloncology.2015.01.008
   PubMed Web of Science ®Google Scholar
• Arantes LMRB, De Carvalho AC, Melendez ME, Carvalho AL. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018;18(1):85–112. doi:10.1080/14737159.2017.1404906
   PubMed Web of Science ®Google Scholar
• Siow MY, Karen Ng LP, Vincent Chong VK, Jamaludin M, Abraham MT, Abdul Rahman ZA, Kallarakkal TG, Yang YH, Cheong SC, Zain RB. Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. Oral Dis. 2014;20(4):345–351. doi:10.1111/odi.12118
   PubMed Web of Science ®Google Scholar
• Qiang H, Zhan X, Wang W, Cheng Z, Ma S, Jiang C. A study on the correlations of the miR-31 expression with the pathogenesis and prognosis of head and neck squamous cell carcinoma. Cancer Biother Radiopharm. 2019;34(3):189–119. doi:10.1089/cbr.2018.2621
   PubMed Web of Science ®Google Scholar
• He Q, Chen Z, Cabay RJ, Zhang L, Luan X, Chen D, Yu T, Wang A, Zhou X. microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol. 2016;57 (7043):15–20. doi:10.1038/nature03552.A
   PubMed Web of Science ®Google Scholar
• Harrandah AM, Fitzpatrick SG, Smith MH, Wang D, Cohen DM, Chan EKL. MicroRNA-375 as a biomarker for malignant transformation in oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(6):743–752. doi:10.1016/j.oooo.2016.07.022
   PubMed Web of Science ®Google Scholar
• Harris T, Jimenez L, Kawachi N, Fan J-B, Chen J, Belbin T, Ramnauth A, Loudig O, Keller CE, Smith R, et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol. 2012;180(3):917–928. doi:10.1016/j.ajpath.2011.12.004
   PubMed Web of Science ®Google Scholar
• Nosrati N, Bakovic M, Paliyath G. Molecular mechanisms and pathways as targets for cancer prevention and progression with dietary compounds. Int J Mol Sci. 2017;18(10):2050. doi:10.3390/ijms18102050
   PubMed Web of Science ®Google Scholar
• Fong LY, Farber JL, Croce CM. Zinc intake, microRNA dysregulation, and esophageal cancer. Aging (Albany NY)). 2016;8(6):1161–1162. doi:10.18632/aging.100978
   PubMedGoogle Scholar
• Liu C, Liang D, Jin J, Li D, Zhang Y, Gao Z, He Y. Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinoma. Thorac Cancer. 2017;8(6):549–557. doi:10.1111/1759-7714.12493
   PubMed Web of Science ®Google Scholar
• El-Naggar A, Chan J, Rubin GJ, Takata T, Slootweg PW. Classification of head and neck tumours. 4th ed. Vol. 9. International Agency for Research on Cancer; 2017.
   Google Scholar
• AMM - Assembléia Médica Mundial. Declaração de Helsinque. 18a Assembléia Médica Mundial. 1964. [accessed 2020 Oct 29]. http://www.ufrgs.br/bioetica/helsin1.htm.
   Google Scholar
• Molina M. d C B, Benseñor IM, Cardoso L. d O, Velasquez-Melendez G, Drehmer M, Pereira TSS, Faria C. P d, Melere C, Manato L, Gomes ALC, et al. Reprodutibilidade e validade relativa do Questionário de Frequência Alimentar do ELSA-Brasil. Cad Saúde Pública. 2013;29(2):379–389. doi:10.1590/S0102-311X2013000600024
   PubMedGoogle Scholar
• Instituto Brasileiro de Geografia e Estatística - IBGE. De Geografia E Estatística - Ibge. 2011. doi:ISSN 0101-4234
   Google Scholar
• Yoshizawa JM., Wong DT. Salivary microRNAs and oral cancer detection. Methods Mol Biol. 2013; 936:313–24. doi:10.1007/978-1-62703-083-0_24
   Google Scholar
• Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14(19):6246–6252. doi:10.1158/1078-0432.CCR-07-5037
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Al Rawi N, Elmabrouk N, Kou RA, Mkadmi S, Rizvi Z, Hamdoon Z. The role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review. Arch Oral Biol. 2021;125:105108 doi:10.1016/j.archoralbio.2021.105108
   PubMed Web of Science ®Google Scholar
• Banikazemi Z, Haji HA, Mohammadi M, Taheripak G, Iranifar E, Poursadeghiyan M, Moridikia A, Rashidi B, Taghizadeh M, Mirzaei H. Diet and cancer prevention: dietary compounds, dietary MicroRNAs, and dietary exosomes. J Cell Biochem. 2018;119(1):185–196. doi:10.1002/jcb.26244
   PubMed Web of Science ®Google Scholar
• Schwenk RW, Vogel H, Schürmann A. Genetic and epigenetic control of metabolic health. Mol Metab. 2013;2(4):337–347. doi:10.1016/j.molmet.2013.09.002
   PubMed Web of Science ®Google Scholar
• Arthur AE, Goss AM, Demark-Wahnefried W, Mondul AM, Fontaine KR, Chen YT, Carroll WR, Spencer SA, Rogers LQ, Rozek LS, et al. Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: Results from a prospective cohort study. Int J Cancer. 2018;143(5):1105–1113. doi:10.1002/ijc.31413
   PubMed Web of Science ®Google Scholar
• Makarem N, Bandera EV, Lin Y, Jacques PF, Hayes RB, Parekh N. Consumption of sugars, sugary foods, and sugary beverages in relation to adiposity-related cancer risk in the Framingham Offspring Cohort (1991–2013). Cancer Prev Res (Phila). 2018;11(6):347–358. doi:10.1158/1940-6207.CAPR-17-0218
   PubMed Web of Science ®Google Scholar
• Yan X, Wang Z, Westberg-Rasmussen S, Tarbier M, Rathjen T, Tattikota SG, Peck BCE, Kanke M, Oxvig C, Frystyk J, et al. Differential impact of glucose administered intravenously and orally on circulating MIR-375 levels in human subjects. J Clin Endocrinol Metabol. 2017;102(10):3749–3755. doi:10.1210/jc.2017-01365
   PubMed Web of Science ®Google Scholar
• El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. miR-375 targets 3’-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes. 2008;57(10):2708–2717. doi:10.2337/db07-1614
   PubMed Web of Science ®Google Scholar
• Keller DM, Clark EA, Goodman RH. Regulation of microRNA-375 by cAMP in pancreatic β-cells. Mol Endocrinol. 2012;26(6):989–999. doi:10.1210/me.2011-1205
   PubMedGoogle Scholar
• Hu J, Vecchia CL, Groh MD, Negri E, Morrison H, Mery L, Cancer C. Dietary cholesterol intake and cancer. Ann Oncol. 2012;23(2):491–500. doi:10.1093/annonc/mdr155
   PubMed Web of Science ®Google Scholar
• Li C, Yang L, Zhang D, Jiang W. Systematic review and meta-analysis suggest that dietary cholesterol intake increases risk of breast cancer. Nutr Res. 2016;36(7):627–635. doi:10.1016/j.nutres.2016.04.009
   PubMed Web of Science ®Google Scholar
• Munir MT, Ponce C, Powell CA, Tarafdar K, Yanagita T, Choudhury M, Gollahon LS, Rahman SM. The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer. J Steroid Biochem Mol Biol. 2018;183:1–9. doi:10.1016/j.jsbmb.2018.05.001
   PubMed Web of Science ®Google Scholar
• Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13(5):342–355. doi:10.1038/nrc3495
   PubMed Web of Science ®Google Scholar
• Zhang L, Ye Y, Tu H, Hildebrandt MA, Zhao L, Heymach JV, Roth JA, Wu X. MicroRNA-related genetic variants in iron regulatory genes, dietary iron intake, microRNAs and lung cancer risk. Ann Oncol. 2017;28(5):1124–1129. doi:10.1093/annonc/mdx046
   PubMed Web of Science ®Google Scholar
• Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, et al. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis. 2012;33(9):1736–1744. doi:10.1093/carcin/bgs204
   PubMed Web of Science ®Google Scholar
• Tan HW, Mo HY, Lau ATY, Xu YM. Selenium species: current status and potentials in cancer prevention and therapy. Int J Mol Sci. 2018;20(1):75. doi:10.3390/ijms20010075
   PubMed Web of Science ®Google Scholar
• Lubiński J, Marciniak W, Muszynska M, Jaworowska E, Sulikowski M, Jakubowska A, Kaczmarek K, Sukiennicki G, Falco M, Baszuk P, et al. Serum selenium levels and the risk of progression of laryngeal cancer. PLoS One. 2018;13(1):e0184873. doi:10.1371/journal.pone.0184873
   PubMed Web of Science ®Google Scholar
• Sarveswaran S, Liroff J, Zhou Z, Nikitin AY, Ghosh J. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer. Int J Oncol. 2010;36(6):1419–1428. doi:10.3892/ijo_00000627
   PubMed Web of Science ®Google Scholar
• McCann MJ, Rotjanapun K, Hesketh JE, Roy NC. Expression profiling indicating low selenium-sensitive microRNA levels linked to cell cycle and cell stress response pathways in the CaCo-2 cell line. Br J Nutr. 2017;117(9):1212–1221. doi:10.1017/S0007114517001143
   PubMed Web of Science ®Google Scholar
• Anderson JJB. Potential health concerns of dietary phosphorus: Cancer, obesity, and hypertension. Ann N Y Acad Sci. 2013;1301(1):1–8. doi:10.1111/nyas.12208
   PubMed Web of Science ®Google Scholar
• Wilson KM, Shui IM, Mucci LA, Giovannucci E. Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study. Am J Clin Nutr. 2015; 101(1):173–83. doi:10.3945/ajcn.114.088716
   Google Scholar
• Zheng T, Boyle P, Willett WC, Hu H, Dan J, Evstifeeva TV, Niu S, MacMahon B. A case-control study of oral cancer in Beijing, People’s Republic of China. Associations with nutrient intakes, foods and food groups. Eur J Cancer. Part B: Oral Oncol. 1993;29(1):45–55. doi:10.1016/0964-1955(93)90010-C
   Web of Science ®Google Scholar
• Panizo S, Naves-Díaz M, Carrillo-López N, Martínez-Arias L, Fernández-Martín JL, Ruiz-Torres MP, Cannata-Andía JB, Rodríguez I. MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calci fi cation mediated by high phosphorus. J Am Soc Nephrol. 2016;27(3):824–834. doi:10.1681/ASN.2014050520
   PubMed Web of Science ®Google Scholar
• Pawlowska E, Szczepanska J, Blasiak J. Pro- And antioxidant effects of Vitamin C in cancer in correspondence to its dietary and pharmacological concentrations. Oxid Med Cell Longev. 2019;2019:7286737. doi:10.1155/2019/7286737
   PubMed Web of Science ®Google Scholar
• Edefonti V, Hashibe M, Parpinel M, Ferraroni M, Turati F, Serraino D, Matsuo K, Olshan AF, Zevallos JP, Winn DM, et al. Vitamin e intake from natural sources and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium. Br J Cancer. 2015;113(1):182–192. doi:10.1038/bjc.2015.149
   PubMed Web of Science ®Google Scholar
• Venturelli S, Sinnberg TW, Berger A, Noor S, Levesque M, Böcker A, Niessner H, Lauer UM, Bitzer M, Garbe C, et al. Epigenetic impacts of ascorbate on human metastatic melanoma cells. Front Oncol. 2014;4:227 doi:10.3389/fonc.2014.00227
   PubMedGoogle Scholar
• Singh B, Ronghe AM, Chatterjee A, Bhat NK, Bhat HK. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. Carcinogenesis. 2013;34(5):1165–1172. doi:10.1093/carcin/bgt026
   PubMed Web of Science ®Google Scholar
• Satake K, Takagi E, Ishii A, Kato Y, Imagawa Y, Kimura Y, Tsukuda M. Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma. Auris Nasus Larynx. 2003;30(4):403–412. doi:10.1016/S0385-8146(03)00091-9
   PubMed Web of Science ®Google Scholar
• Bochen F, Balensiefer B, Körner S, Bittenbring JT, Neumann F, Koch A, Bumm K, Marx A, Wemmert S, Papaspyrou G, et al. Vitamin D deficiency in head and neck cancer patients–prevalence, prognostic value and impact on immune function. OncoImmunology. 2018;7(9):e1476817. doi:10.1080/2162402X.2018.1476817
   PubMed Web of Science ®Google Scholar
• Provvisiero DP, Negri M, de Angelis C, Di Gennaro G, Patalano R, Simeoli C, Papa F, Ferrigno R, Auriemma RS, De Martino MC, et al. Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep. 2019;9(1):1–13. doi:10.1038/s41598-019-48081-9
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Ali MM. Methyl donor micronutrients that modify DNA methylation and cancer outcome. Nutrients. 2019;11(3):608–630. doi:10.3390/nu11030608
   PubMed Web of Science ®Google Scholar
• Gaździcka J, Gołąbek K, Strzelczyk JK, Ostrowska Z. Epigenetic modifications in head and neck cancer. Biochem Genet. 2020;58(2):213–244. doi:10.1007/s10528-019-09941-1
   PubMed Web of Science ®Google Scholar
• Colacino JA, Arthur AE, Dolinoy DC, Sartor MA, Duffy SA, Chepeha DB, Bradford CR, Walline HM, Mchugh JB, Silva ND, et al. Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas. Epigenetics. 2012;7(8):883–891. doi:10.4161/epi.21038
   PubMed Web of Science ®Google Scholar